![](/img/cover-not-exists.png)
Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study
Norhammar, Anna, Bodegard, Johan, Nyström, Thomas, Thuresson, Marcus, Rikner, Klas, Nathanson, David, Eriksson, Jan WLanguage:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13852
Date:
August, 2019
File:
PDF, 1.22 MB
english, 2019